Medication info

KyungBang Ciprofloxacin Hydrochloride Hydrate Tablets

Prescription medicationTabletOralExpired
Ingredient · strength
Ciprofloxacin Hydrochloride Hydrate›291mg / 1 tablet
Manufacturer / importer
KyungBang Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 202002162 · Approved 2020.03.27

This product's status changed to Expired on 2025.03.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of bacterial infections (respiratory tract, urinary tract, skin, etc.)
Who takes it
Adults
Adult dose
○ Usual adult dose: Administer ciprofloxacin 250 ~ 500 mg orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg twice daily. For acute infections, treatment generally continues for 5 ~ 10 days, and administration should continue for at least 3 days after symptoms have disappeared. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients on hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following equations. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the single dose may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition should be monitored carefully after administration. The dose may be adjusted appropriately according to symptoms.

Ingredients

Manufacturer
KyungBang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of bacterial infections (respiratory tract, urinary tract, skin, etc.)

  • Respiratory infections excluding acute bronchitis
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • external otitis
  • chronic cholesteatomatous otitis media
  • bacterial prostatitis
  • acute simple cystitis
  • acute pyelonephritis
  • complicated urinary tract infections
  • gonococcal cervicitis
View approved original text

This drug is effective against various bacteria and is used to treat respiratory infections excluding acute bronchitis and community-acquired pneumonia. It is also applicable for infections of the ear, nose, and throat, bacterial prostatitis, acute simple cystitis, and acute pyelonephritis among urinary tract infections. It is utilized for the treatment of various infections including gastrointestinal infections, infections of the biliary tract, skin and soft tissue infections, wounds, bone and joint infections, and gynecological infections. Due to being a fluoroquinolone, it is used restrictively when other treatments are difficult in cases of acute bacterial rhinosinusitis, acute bacterial exacerbation of chronic bronchitis, and acute bacterial exacerbation of COPD. It is effective for the treatment of extensive bacterial infections and helps to improve infection symptoms.

How to take

Adult dose

○ Usual adult dose: Administer ciprofloxacin 250 ~ 500 mg orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg twice daily. For acute infections, treatment generally continues for 5 ~ 10 days, and administration should continue for at least 3 days after symptoms have disappeared. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients on hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following equations. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the single dose may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition should be monitored carefully after administration. The dose may be adjusted appropriately according to symptoms.

Precautions

This drug can cause serious side effects such as tendonitis or tendon rupture, so if these symptoms occur, use should be discontinued immediately. In particular, it should not be administered to patients with myasthenia gravis as symptoms may worsen. Use is not recommended for pregnant women, women who may become pregnant, nursing mothers, and children under 18 years of age. This drug may affect the nervous system, leading to symptoms such as dizziness, confusion, and convulsions. If these symptoms occur, medical consultation should be sought immediately. Additionally, strong sunlight or UV exposure should be avoided while taking this drug, and use should be discontinued if photosensitivity reactions are suspected. Diabetic patients should monitor blood sugar closely as changes may occur. This drug has many interactions with other medications, so caution is necessary when used in combination, especially with certain anticoagulants, anticonvulsants, and some anti-inflammatory drugs. Elderly patients are at higher risk for adverse reactions due to decreased kidney function; therefore, dose adjustments and caution are necessary. Overdosage may result in kidney damage, so prescribed dosages must be strictly adhered to. Store in a place out of reach of children and keep away from direct sunlight and UV light.

Side effects

Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, hemoglobin decrease, hematocrit decrease, granulocytopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, allergic edema, angioedema, anaphylactic reactions, anaphylactoid shock, serum sickness-like reactions, anorexia, decreased food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory disturbances, sensory loss, loss of taste, tremor, convulsions, vertigo, mental confusion, seizures, drowsiness, migraine, coordination disorders, olfactory disorders, anosmia, sensory hypersensitivity, increased intracranial pressure, ataxia, peripheral neuropathy, polyneuropathy, vision disorders, color vision deficiency, diplopia, tinnitus, hearing loss, transient hearing loss, hearing impairment, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, decreased appetite, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal bloating, dyspepsia, colitis with bloody stools, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver impairment, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechial hemorrhage, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tone and spasms, joint swelling, myasthenia, muscle weakness, partial or complete tendon rupture, exacerbation of severe myasthenia gravis, kidney impairment, increased BUN, elevated serum creatinine, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, unexplained pain, discomfort, fever, lethargy, edema, sweating, gait disturbances, maculopapular rash, purpuric rash, injection site rash, injection site itching, injection site urticaria, aneurysm, aortic dissection, heart valve regurgitation, heart valve insufficiency, myalgia, weakness, increased creatine kinase, elevated serum and urine myoglobin, rhabdomyolysis, cough, abnormal chest X-ray, eosinophilia, interstitial pneumonia, visual impairment

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to prevent air exposure and is safest when stored at room temperature between 1 and 30 degrees Celsius. Proper temperature and sealed conditions can maintain the drug's efficacy and prevent deterioration.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.